Related references
Note: Only part of the references are listed.Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans
Maria Amann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
Volker Heinemann et al.
CANCER TREATMENT REVIEWS (2009)
Cancer Stem Cells: Controversial or Just Misunderstood?
Craig T. Jordan
CELL STEM CELL (2009)
Mode of cytotoxic action of T cell-engaging BiTE antibody MT110
Cornelia Haas et al.
IMMUNOBIOLOGY (2009)
Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release
Maria Amann et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype
Barbara Gonzalez et al.
STEM CELLS (2009)
On the abundance of EpCAM on cancer stem cells
Olivier Gires et al.
NATURE REVIEWS CANCER (2009)
Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables
Sagit Prince et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3
Maria Amann et al.
CANCER RESEARCH (2008)
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2008)
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer et al.
CANCER RESEARCH (2008)
Module map of stem cell genes guides creation of epithelial cancer stem cells
David J. Wong et al.
CELL STEM CELL (2008)
Cancer: Inappropriate expression of stem cell programs?
Yingzi Wang et al.
CELL STEM CELL (2008)
CD44 and EpCAM: Cancer-Initiating Cell Markers
Rachid Marhaba et al.
CURRENT MOLECULAR MEDICINE (2008)
EpCAM expression in normal, non-pathological tissues
Eva Schmelzer et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Scott J. Dylla et al.
PLOS ONE (2008)
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
Ralf Bargou et al.
SCIENCE (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance
D. Fong et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Evaluating therapeutic efficacy against cancer stem cells: New challenges posed by a new paradigm
Jean C. Y. Wang
CELL STEM CELL (2007)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
M. A. Chaudry et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
Gilbert Spizzo et al.
GYNECOLOGIC ONCOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3
B Schlereth et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
K Brischwein et al.
MOLECULAR IMMUNOLOGY (2006)
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells
S Offner et al.
MOLECULAR IMMUNOLOGY (2006)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
P Went et al.
BRITISH JOURNAL OF CANCER (2006)
BiTEs: bispecific antibody constructs with unique anti-tumor activity
E Wolf et al.
DRUG DISCOVERY TODAY (2005)
Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct
P Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct
B Schlereth et al.
CANCER RESEARCH (2005)
A revival of bispecific antibodies
P Kufer et al.
TRENDS IN BIOTECHNOLOGY (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
M Münz et al.
ONCOGENE (2004)
Loss of E-cadherin expression correlates with poor differentiation and invasion into a acent organs in gastric adenocarcinomas
HC Chen et al.
CANCER LETTERS (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ep-CAM overexpression in breast cancer as a predictor of survival
G Gastl et al.
LANCET (2000)
Share Paper
